SCHEMBL6565240

SCHEMBL6565240

CC(=O)c1nc2ccc(Cl)cc2cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.43
KMT2A Q03164 2/20 0.40
DYRK1A Q13627 1/20 0.40
FSCN1 Q16658 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
DAO P14920 2/20 0.39
MAOB P27338 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ERN1 O75460 1/20 0.37
PIM1 P11309 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
EGFR P00533 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
PTGS2 P35354 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565660 0.87 KMT2A (0.43) RXFP1KMT2ADYRK1AFSCN1DAO
SCHEMBL8632228 0.81 MEN1 (0.50) KMT2ADYRK1APDE3BPDE3ADAO
SCHEMBL22237927 0.80 ERN1 (0.37) KMT2ADYRK1AERN1KDM4EMEN1
SCHEMBL2720662 0.80 TSHR (0.44) KMT2ADYRK1APDE3BPDE3ADAO
SCHEMBL31220360 0.80 ALDH1A1 (0.43) DYRK1AERN1PIM1PIM2ALDH1A1
SCHEMBL27751906 0.80 RXFP1 (0.42) RXFP1KMT2ADYRK1AFSCN1PDE3B
SCHEMBL6567169 0.78 ALDH1A1 (0.52) KMT2ADYRK1APDE3BPDE3AERN1
SCHEMBL2975427 0.77 KDM4E (0.56) KMT2APIM1PTGS2TDP1KDM4E
SCHEMBL17616107 0.76 KMT2A (0.47) KMT2ADYRK1AFSCN1MAOBPIM1
SCHEMBL6565239 0.75 PDE3B (0.49) KMT2APDE3BPDE3AHDAC6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0765871-B1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors FIBROGEN INC (US) 2004-03-31 EP disclosed
CN-1120157-C Substituted quinoline-2-carboxamides, process for their preparation and their use as pharmaceuticals, and intermediates thereof FIBER GENE CORP (US) 2003-09-03 CN disclosed
CN-1282737-A Intermediate product used for preparing substituted quinoline-2-formamide MOECHST AG (DE) 2001-02-07 CN disclosed
US-5726305-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-10 US disclosed
US-5719164-A Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates HOECHST AKTIENGESELLSCHAFT (DE) 1998-02-17 US disclosed
EP-0765871-A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1997-04-02 EP disclosed